山形大学 · 医学部附属病院

研究キーワードhematologic malignancies・multiple myeloma・mantle cell lymphoma・acute leukemia-associated DIC・pure red cell aplasia・iron deficiency biomarkers・anti-ganglioside neuropathy・recombinant thrombomodulin

ここは公開データのプレビューです。個別の適合理由、連絡角度、保存機能はログイン後に利用できます。

• Elranatamab in Japanese patients with relapsed/refractory multiple myeloma: results from MagnetisMM-2 and MagnetisMM-3 ，japanese journal of clinical oncology，2024年09月2024 · Shinsuke Iida,Satoshi Ito,Hisayuki Yokoyama
• Phase 2 study of ibrutinib plus venetoclax in Japanese patients with relapsed/refractory mantle cell lymphoma ，international journal of clinical oncology，29(2) 232-240，2024年02月2024 · Hideki Goto,Satoshi Ito,Masahiro Kizaki,masaki Yamaguchi
• [Immune-mediated neuropathy with anti-ganglioside antibodies in diffuse large B-cell lymphoma].，[Rinsho ketsueki] The Japanese journal of clinical hematology，60(7) 761-766，2019年2019 · Yanagiya R, Ito S, Yamada A, Aizawa K, Shiono Y, Inokura K, Toubai T, Kato Y, Honda K, Ishizawa K
• Evaluation of the safety and efficacy of recombinant soluble thrombomodulin for patients with disseminated intravascular coagulation associated with acute leukemia: multicenter prospective study by the Tohoku Hematology Forum.，International journal of hematology，105(5) 606-613，2017年05月2017 · Yokoyama H, Takahashi N, Katsuoka Y, Inomata M, Ito T, Meguro K, Kameoka Y, Tsumanuma R, Murai K, Noji H, Ishizawa K, Ito S, Onishi Y, Harigae H, Tohoku Hematology Forum

• 公式プロフィール